Industry Growth Insights published a new data on “Smart Inhalers Market”. The research report is titled “Smart Inhalers Market research by Types (Digital Dose Inhalers, Dry Powder Inhalers, Nebulizers, Other), By Applications (Asthma, COPD, Other), By Players/Companies Sensirion, 3M, Adherium Limited, AstraZeneca, Boehringer Ingelheim, Cohero Health, GlaxoSmithKline, Glenmark Pharmaceuticals, Novartis, OPKO Health (Inspiro Medical Ltd.), Sensirion, Propeller Health, Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations), Vectura Group”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Smart Inhalers Market Research Report
By Type
Digital Dose Inhalers, Dry Powder Inhalers, Nebulizers, Other
By Application
Asthma, COPD, Other
By Companies
Sensirion, 3M, Adherium Limited, AstraZeneca, Boehringer Ingelheim, Cohero Health, GlaxoSmithKline, Glenmark Pharmaceuticals, Novartis, OPKO Health (Inspiro Medical Ltd.), Sensirion, Propeller Health, Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations), Vectura Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
161
Number of Tables & Figures
113
Customization Available
Yes, the report can be customized as per your need.
Global Smart Inhalers Market Report Segments:
The global Smart Inhalers market is segmented on the basis of:
Types
Digital Dose Inhalers, Dry Powder Inhalers, Nebulizers, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Asthma, COPD, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sensirion
- 3M
- Adherium Limited
- AstraZeneca
- Boehringer Ingelheim
- Cohero Health
- GlaxoSmithKline
- Glenmark Pharmaceuticals
- Novartis
- OPKO Health (Inspiro Medical Ltd.)
- Sensirion
- Propeller Health
- Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations)
- Vectura Group
Highlights of The Smart Inhalers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Digital Dose Inhalers
- Dry Powder Inhalers
- Nebulizers
- Other
- By Application:
- Asthma
- COPD
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Smart Inhalers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Smart inhalers are a type of asthma medication that use sensors to measure how much medicine is being inhaled and then release the correct dose. This helps to avoid over-medication and reduces the risk of side effects.
Some of the major companies in the smart inhalers market are Sensirion, 3M, Adherium Limited, AstraZeneca, Boehringer Ingelheim, Cohero Health, GlaxoSmithKline, Glenmark Pharmaceuticals, Novartis, OPKO Health (Inspiro Medical Ltd.), Sensirion, Propeller Health, Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations), Vectura Group.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Smart Inhalers Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Smart Inhalers Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Smart Inhalers Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Smart Inhalers Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Smart Inhalers Market Size & Forecast, 2018-2028 4.5.1 Smart Inhalers Market Size and Y-o-Y Growth 4.5.2 Smart Inhalers Market Absolute $ Opportunity
Chapter 5 Global Smart Inhalers Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Smart Inhalers Market Size Forecast by Type
5.2.1 Digital Dose Inhalers
5.2.2 Dry Powder Inhalers
5.2.3 Nebulizers
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Smart Inhalers Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Smart Inhalers Market Size Forecast by Applications
6.2.1 Asthma
6.2.2 COPD
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Smart Inhalers Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Smart Inhalers Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Smart Inhalers Analysis and Forecast
9.1 Introduction
9.2 North America Smart Inhalers Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Smart Inhalers Market Size Forecast by Type
9.6.1 Digital Dose Inhalers
9.6.2 Dry Powder Inhalers
9.6.3 Nebulizers
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Smart Inhalers Market Size Forecast by Applications
9.10.1 Asthma
9.10.2 COPD
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Smart Inhalers Analysis and Forecast
10.1 Introduction
10.2 Europe Smart Inhalers Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Smart Inhalers Market Size Forecast by Type
10.6.1 Digital Dose Inhalers
10.6.2 Dry Powder Inhalers
10.6.3 Nebulizers
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Smart Inhalers Market Size Forecast by Applications
10.10.1 Asthma
10.10.2 COPD
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Smart Inhalers Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Smart Inhalers Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Smart Inhalers Market Size Forecast by Type
11.6.1 Digital Dose Inhalers
11.6.2 Dry Powder Inhalers
11.6.3 Nebulizers
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Smart Inhalers Market Size Forecast by Applications
11.10.1 Asthma
11.10.2 COPD
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Smart Inhalers Analysis and Forecast
12.1 Introduction
12.2 Latin America Smart Inhalers Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Smart Inhalers Market Size Forecast by Type
12.6.1 Digital Dose Inhalers
12.6.2 Dry Powder Inhalers
12.6.3 Nebulizers
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Smart Inhalers Market Size Forecast by Applications
12.10.1 Asthma
12.10.2 COPD
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Smart Inhalers Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Smart Inhalers Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Smart Inhalers Market Size Forecast by Type
13.6.1 Digital Dose Inhalers
13.6.2 Dry Powder Inhalers
13.6.3 Nebulizers
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Smart Inhalers Market Size Forecast by Applications
13.10.1 Asthma
13.10.2 COPD
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Smart Inhalers Market: Competitive Dashboard
14.2 Global Smart Inhalers Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sensirion
14.3.2 3M
14.3.3 Adherium Limited
14.3.4 AstraZeneca
14.3.5 Boehringer Ingelheim
14.3.6 Cohero Health
14.3.7 GlaxoSmithKline
14.3.8 Glenmark Pharmaceuticals
14.3.9 Novartis
14.3.10 OPKO Health (Inspiro Medical Ltd.)
14.3.11 Sensirion
14.3.12 Propeller Health
14.3.13 Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations)
14.3.14 Vectura Group